The Effect of Saphenous Nerve Block on Knee Pain in Primary Gonarthrosis patients; a randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007717

Enrollment

Registered

2022-09-19

Start date

2022-09-01

Completion date

Unknown

Last updated

2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Procedure/Surgery : Patients who agreed to the study are divided into control group and saphenous nerve block groups (R group and RT group) randomly. One doctor who has confirmed the group assig

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with knee pain, swelling, or reduced range of movement due to gonarthrosis

Exclusion criteria

Exclusion criteria: Except for patients under the age of 20, over 70, weighing under 45kg or over 100kg, those with an American Society of Anesthesiologists grade 3 or above, those allergic to local anesthetics, and other serious cardiovascular, respiratory, or hematological abnormalities

Design outcomes

Primary

Measure	Time frame
Visual Analog Scale	—

Secondary

Measure	Time frame
Visual Analog Scale	—

Countries

Korea, Republic of

Contacts

Public ContactHyunho Kim

Chung-Ang Univerisity Hospital

hyumo@naver.com+82-2-6299-2577

Outcome results